Biosite Inc. Recalls Cardiac Marker Test
On Tuesday, the company voluntarily recalled 401 of its Triage Cardiac Panel kits because of “reports of low recovery of quality control samples containing Creatine Kinase MB (CK-MB), troponin I and myoglobin on the affected lot."
“Although there have been no reported issues of patient misdiagnosis associated with this...
To view the full article, register now.